HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.

Abstract
The chromosomal translocation t(12; 22)(p13;q11) in human myeloid leukemia generates an MN1-TEL (meningioma 1-translocation-ETS-leukemia) fusion oncoprotein. This protein consists of N-terminal MN1 sequences, a transcriptional coactivator fused to C-terminal TEL sequences, an ETS (E26 transformation-specific) transcription factor. Enforced expression of MN1-TEL in multipotent hematopoietic progenitors in knock-in mice perturbed growth and differentiation of myeloid as well as lymphoid cells. Depending on obligatory secondary mutations, these mice developed T-cell lympholeukemia. Here we addressed the role of MN1-TEL in myeloid leukemogenesis using the same mouse model. Expression of MN1-TEL enhanced the growth of myeloid progenitors in an interleukin 3/stem cell factor (IL-3/SCF)-dependent manner in vitro whereas 10% of MN1-TEL-expressing mice developed altered myelopoiesis with severe anemia after long latency. Coexpression of MN1-TEL and IL-3, but not SCF, rapidly caused a fatal myeloproliferative disease rather than acute myeloid leukemia (AML). Because MN1-TEL+ AML patient cells overexpress HOXA9 (homeobox A9), we tested the effect of coexpression of MN1-TEL and HOXA9 in mice and found that 90% of MN1-TEL+/HOXA9+ mice developed AML much more rapidly than control HOXA9+ mice. Thus, the leukemogenic effect of MN1-TEL in our knock-in mice is pleiotropic, and the type of secondary mutation determines disease outcome.
AuthorsHiroyuki Kawagoe, Gerard C Grosveld
JournalBlood (Blood) Vol. 106 Issue 13 Pg. 4269-77 (Dec 15 2005) ISSN: 0006-4971 [Print] United States
PMID16105979 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytokines
  • ETS translocation variant 6 protein
  • Homeodomain Proteins
  • Mn1 protein, mouse
  • Oncogene Proteins
  • Proto-Oncogene Proteins c-ets
  • Proto-Oncogene Proteins c-myc
  • Repressor Proteins
  • Trans-Activators
  • Tumor Suppressor Proteins
  • homeobox protein HOXA9
Topics
  • Animals
  • Cell Proliferation
  • Cells, Cultured
  • Cytokines (pharmacology)
  • Gene Expression Regulation, Neoplastic
  • Homeodomain Proteins (genetics, metabolism)
  • Humans
  • Leukemia, Myeloid, Acute (genetics, metabolism, pathology)
  • Mice
  • Mice, Transgenic
  • Myeloid Progenitor Cells (cytology, drug effects, metabolism)
  • Oncogene Proteins (genetics, metabolism)
  • Proto-Oncogene Proteins c-ets (genetics, metabolism)
  • Proto-Oncogene Proteins c-myc (metabolism)
  • Repressor Proteins (genetics, metabolism)
  • Trans-Activators
  • Transgenes (genetics)
  • Tumor Suppressor Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: